Altrova Health (FRA:WF8) Total Receivables: €0.09 Mil (As of Mar. 2026)


What is Altrova Health Total Receivables?

Altrova Health FRA:WF8 Total Receivables is €0.09 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Altrova Health's Total Receivables for the quarter that ended in Mar. 2026 was €0.09 Mil.

Altrova Health Total Receivables Related Terms

Altrova Health Total Receivables Historical Data

* Premium members only.

The historical data trend for Altrova Health's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altrova Health Total Receivables Chart

Altrova Health Annual Data
Trend Sep23 Sep24 Sep25
Total Receivables
0.10 0.00 0.06

Altrova Health Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.06 0.06 0.07 0.09

Altrova Health Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €0.09 Mil mean?
Altrova Health (FRA:WF8) has a Total Receivables of €0.09 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Altrova Health and its competitors.
Is Altrova Health's Total Receivables too high?
Altrova Health's current Total Receivables is €0.09 Mil.
How does Altrova Health's Total Receivables compare to BLK and BX?
Altrova Health's Total Receivables of €0.09 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for an Asset Management company?
A good Total Receivables depends on the Asset Management industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Altrova Health and its competitors. Altrova Health's current Total Receivables is €0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current Total Receivables of €0.09 Mil. The current Total Receivables is €0.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current Total Receivables is €0.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USAROVA:Canada
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.